Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
These results were consistent with the per protocol analysis (Figure 2)
Head-to-head post-registration trial or a real-world data study would be helpful
The STEP-9 trial showed convincing improvement in symptoms and less use of pain medication in people with knee osteoarthritis randomized to semaglutide 2.4 mg once weekly, Drucker said
"These phase 2b clinical trial results for GIP/GLP-1 RA are unprecedented, and the impressive blood glucose and weight reductions seen may lead to a new treatment option for people with type 2 diabetes," said Two statistical approaches were used to evaluate the efficacy of four doses of GIP/GLP-1 RA (1 mg, 5 mg, 10 mg, 15 mg) compared to placebo and dulaglutide 1.5 mg in people with type 2 diabetes
